期刊文献+

曲美他嗪治疗冠心病心力衰竭 被引量:3

下载PDF
导出
摘要 目的评价联合曲美他嗪治疗冠心病心力衰竭患者的疗效。方法选择冠心病心力衰竭患者62例,分为2组,A组33例,常规治疗加曲美他嗪;B组29例,仅为常规治疗。按NYHA分组评价曲美他嗪疗效,以心电图ST-T的变化判断心肌缺血程度。结果A组总有效率为93·8%,B组为75·8%,两组相比差异有显著性(P<0·05),两组中,冠心病心力衰竭心肌缺血改善总有效率差异显著(P<0·05)。治疗期间未发生严重不良反应。结论曲美他嗪加常规治疗能改善冠心病心力衰竭患者的心功能,同时有效的改善心肌缺血状态。提示曲美他嗪是治疗冠心病心力衰竭良好的辅助药物。
作者 刘畅
出处 《医药论坛杂志》 2006年第3期66-66,68,共2页 Journal of Medical Forum
  • 相关文献

参考文献5

  • 1Cornel JH, Baxll, Fioretti PM, et al. Prediction of improvement of ventricular function after revascularization: F - fl-morodeoxyglucose singlephoton emission computed tomography vs lowdose dobutamine echocardiography. Eur Heart J, 1997,18:941-948.
  • 2Yazaki Y, Isobe M,Takahashi W,et ah Assessment of myocardial fatty acid metabolic abnormalities in patients with idiopathic dilated cardiomyopathy using ^123Ⅰ BMIPP SPECT. Correlation with clinicopathological findings and clinical course. Heart, 1999,81 : 153-159.
  • 3Kantor PF, Lucien A, kozak R, Lopaschuk GD. The antianginal drug trimitazidine shifts cardiac energy matabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochonddrial long-chain 3-ketoacy 1 coenzyme A thiolase. Circ Res ,2000,86:580-588.
  • 4Ferrari R, Agnoletti L, Cominl L,et al. Oxidative stress during myocardial ischemia and heart failure. Eur Heart J,1998,19:2-11.
  • 5周国鹏,赵志杰,祁芸云,唐朝枢.三甲氧苄嗪和缺血性心脏病[J].心血管病学进展,2001,22(1):23-24. 被引量:2

二级参考文献6

  • 1Lu C,Am J Cardiol,1998年,82卷,7期,898页
  • 2Guarnieri C,Basic Res Cardiol,1997年,92卷,2期,90页
  • 3Veitch K,Am J Cardiol,1995年,76卷,6期,25B页
  • 4Astarie Dequeker C,J Cardiovasc Pharmacol,1994年,23卷,3期,401页
  • 5Koning M M,Cardiovasc Drugs Ther,1993年,7卷,5期,807页
  • 6Devynck M A,Eur J Pharmacol,1993年,245卷,2期,105页

共引文献1

同被引文献73

  • 1张素蓉.他汀类药物在冠状动脉粥样硬化性心脏病中的防治作用[J].当代医学,2008,14(14). 被引量:2
  • 2张之亮,马俊爱.曲美他嗪治疗冠心病心力衰竭的临床观察[J].中国心血管杂志,2006,11(4):301-303. 被引量:38
  • 3Stanley WC.Metabolic therapy in the treatment of ischemic heart disease:the pharmacology of trimetazidine[J].Fun Clin Pha,2003,17(2):133-145.
  • 4Narzilli M,Klein WW.Efficacy and tolerability of trimetazidine in stable angina:a meta-analysis of randomized double-blind controlled trials[J].Coron Art Dis,2003,14(2):171.
  • 5Mc Clellan KJ,Plosker GL.Trimetazidine:A review of its use in stable angina pectoris and other coronary conditions[J].Drugs,1999,50:143-157.
  • 6Desideri A,Celegon L.Metabolic management of ischemic heart disease:clinical data with trimetazidine[J].Am J Cardiol,1998,82(5A):50K-53K.
  • 7Szwed H,Pachocki R,Domzal-Bochenska M.Efficac ité et tolérance de la trimétazidine,antiangoreux métabolique,en association avec un antiangoreux hémodynamique dans langor déffort stable[J].Presse Med,2000,29:533-538.
  • 8Rogacka D,Guzik P,Wykrεtowicz A,et al.Effects of trimetazidine on clinical symptoms and tolerance of exercise of patients with syndrome X:a preliminary study[J].Coren Arterg Dis,2000,11:171-177.
  • 9Lu C,Dabrowski P,Fragasso G,et al.Effects of trimetazidine on ischemic left ventricular dysfunction in patients with coronary artery disease[J].Heart,1998,82:898-901.
  • 10Manchanda SC.Krishnaswami S Combination treatment with trimetazidine and diltiazem in stable angina pectoris[J].Heart,1997,78(4):353-357.

引证文献3

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部